Back to Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 5

Potential cellular and regenerative approaches for the treatment of Parkinson’s disease

Authors Lane EL, Handley OJ, Rosser AE, Dunnett SB

Published 10 October 2008 Volume 2008:4(5) Pages 835—845


Emma L Lane, Olivia J Handley, Anne E Rosser, Stephen B Dunnett

Brain Repair Group, School of Biosciences, Cardiff University, CF10 3US, UK

Abstract: Parkinson’s disease is most commonly treated with a range of pharmacotherapeutics, with the more recent introduction of surgical techniques including deep-brain stimulation. These have limited capabilities to improve symptoms of the disease in more advanced stages, thus new therapeutic strategies including the use of viral vectors and stem cells are in development. Providing a continuous supply of dopamine to the striatum in an attempt to improve the treatment of motor symptoms using enzymes in the dopamine synthesis and machinery is one approach. Alternatively, there are tools which may serve to both protect and encourage outgrowth of surviving neurons using growth factors or to directly replace lost innervation by transplantation of primary tissue or stem cell-derived dopaminergic neurons. We summarize some of the potential therapeutic approaches and also consider the recent EU directives on practical aspects of handling viral vectors, cells and tissues, and in the running of clinical trials in Europe which impact on their development.

Keywords: transplantation, viral vector, stem cells, ethics, European Union directive

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]